These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30155912)

  • 41. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consistent causal effect estimation under dual misspecification and implications for confounder selection procedures.
    Gruber S; van der Laan MJ
    Stat Methods Med Res; 2015 Dec; 24(6):1003-8. PubMed ID: 22368176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifiability and estimation of causal mediation effects with missing data.
    Li W; Zhou XH
    Stat Med; 2017 Nov; 36(25):3948-3965. PubMed ID: 28783880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statistical significance--a misconstrued notion in medical research.
    Nurminen M
    Scand J Work Environ Health; 1997 Jun; 23(3):232-5. PubMed ID: 9243735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.
    Nie H; Cheng J; Small DS
    Biometrics; 2011 Dec; 67(4):1397-405. PubMed ID: 21385167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A bivariate approach to meta-analysis.
    Van Houwelingen HC; Zwinderman KH; Stijnen T
    Stat Med; 1993 Dec; 12(24):2273-84. PubMed ID: 7907813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating causal effects using prior information on nontrial treatments.
    Bond SJ; White IR
    Clin Trials; 2010 Dec; 7(6):664-76. PubMed ID: 20817650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifiability of subgroup causal effects in randomized experiments with nonignorable missing covariates.
    Ding P; Geng Z
    Stat Med; 2014 Mar; 33(7):1121-33. PubMed ID: 24122906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Causal inference from randomized trials in social epidemiology.
    Kaufman JS; Kaufman S; Poole C
    Soc Sci Med; 2003 Dec; 57(12):2397-409. PubMed ID: 14572846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correcting the Standard Errors of 2-Stage Residual Inclusion Estimators for Mendelian Randomization Studies.
    Palmer TM; Holmes MV; Keating BJ; Sheehan NA
    Am J Epidemiol; 2017 Nov; 186(9):1104-1114. PubMed ID: 29106476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ON THE USE OF NONPARAMETRIC BOUNDS FOR CAUSAL EFFECTS IN NULL RANDOMIZED TRIALS.
    Gabriel EE; Sachs MC
    Am J Epidemiol; 2021 Oct; 190(10):2231. PubMed ID: 34017983
    [No Abstract]   [Full Text] [Related]  

  • 55. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discussions.
    Vansteelandt S
    Biometrics; 2009 Sep; 65(3):686-9; discussion 689-91. PubMed ID: 18759845
    [No Abstract]   [Full Text] [Related]  

  • 58. Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods.
    Ahern J; Hubbard A; Galea S
    Am J Epidemiol; 2009 May; 169(9):1140-7. PubMed ID: 19270051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inference for Surrogate Endpoint Validation in the Binary Case.
    Bebu I; Mathew T; Agan B
    J Biopharm Stat; 2015; 25(6):1272-84. PubMed ID: 25616958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.